LifeLabs recognized by Forbes as one of Canada’s Best Employers for Diversity in 2022
Toronto, Ontario, July 14, 2022 (GLOBE NEWSWIRE) -- LifeLabs has been named one of Canada’s Best Employers for Diversity in...
Year: 2022
Apellis Announces Five Oral Presentations in Geographic Atrophy (GA) Highlighted at the ASRS Annual Scientific Meeting
WALTHAM, Mass., July 14, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in...
Stagwell’s (STGW) The Harris Poll Sponsors Annual Fierce Pharma PR & Communications Summit Presenting Results on Healthcare Communications and Reputation in the Pharma Industry
NEW YORK, July 13, 2022 /PRNewswire/ -- The Harris Poll, a Stagwell (NASDAQ: STGW) agency, is proud to be a sponsor...
Spectral Medical Highlights From Vicenza Course 2022
Video replay of sponsored symposium explaining endotoxemic septic shock and the case for hemoperfusion therapyTORONTO, July 14, 2022 (GLOBE NEWSWIRE)...
NASA Administrator Joins President Biden’s Cancer Cabinet
WASHINGTON, July 13, 2022 /PRNewswire/ -- President Joe Biden announced Wednesday he has appointed NASA Administrator Bill Nelson as one...
Sitka, Where Legends Grow
Canada's only "micro-park" craft cannabis cultivation facility, licensed for individual growers to cultivate in their own 4,250 - 6,000 sq....
OM INVESTORS: September 6, 2022 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
SAN FRANCISCO--(BUSINESS WIRE)--$OM #InvestorAlert--The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been...
Horizon Technology Finance Provides Second Quarter 2022 Portfolio Update
- Horizon Platform Originates Record $192 Million of New Loans in Q2, Including $137 Million of New Loans for HRZN...
NervGen Pharma Closes US$15MM Private Placement and Appoints Dr. Adam Rogers to Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - July 14, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" the "Company"), a...
Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year
Company Reports Record Revenue and Improved MarginsREDWOOD CITY, CA / ACCESSWIRE / July 14, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity"...
Merit Medical Systems to Announce Second Quarter Results on July 27, 2022
SOUTH JORDAN, Utah, July 14, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and...
Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at Controlled Release Society 2022
Demonstrates OBDS Device Performance and Bioavailability in Animal ModelsSAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq:...
Chiesi tracks actions taken for a healthier, more sustainable future
Chiesi’s Annual and Sustainability Report 2021 is released today;Progress toward business, environmental and social targets is strong;Company is joining forces...
Alignment Healthcare to Enter Texas in 2023, Introducing Its Award-Winning Medicare Advantage Plans to Medicare-Eligible Adults in El Paso, Hudspeth Counties
ORANGE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced more details...
Xequel Bio Announces Positive Results from Phase 1b Study of iNexin™, a Novel aCT1 Ophthalmic Solution
Excellent Safety and Tolerability Profile for iNexin™ for the Treatment of Corneal Injury Early Efficacy Signals Provide Rationale to Advance...
Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Test for Pediatric Hydrocephalus Patients
Groundbreaking Medical Device Company Unveils AI-Powered Software that Improves Diagnostic Imaging Experience for Young PatientsAUSTIN, Texas, July 14, 2022 (GLOBE...
Revelation Biosciences Inc. Completes Database Lock for its Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis
-Topline Data expected in the last week of July-SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ:...
MDbio Start Clinical Trials for Pharmaceutical-Grade Products That Target Sleeplessness, Anxiety and Pain; Expected Retail From 2023
Los Angeles, CA, July 14, 2022 (GLOBE NEWSWIRE) -- MDbio are a leading plant-based, wellness solution who provide safe, pharmaceutical-grade...
Allied Corp Successfully Ships Second Commercial Cannabis Flower Export From Colombia to International Market
KELOWNA, British Columbia, July 14, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
New two-year data confirm Roche’s Vabysmo improves vision with fewer treatments for people with neovascular age-related macular degeneration
In the TENAYA and LUCERNE studies, more than 60% of Vabysmo patients could be treated every four months at two...